Published on 31 May 2024 on The Business Journals
Summit Therapeutics sees stock soar 272% after lung cancer clinical trial - Silicon Valley Business...
Summit Therapeutics Inc. investors sent the company's stock up 272% Thursday following the release...
NYSE.ABBV price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free